Please assess the completion status of the following clinical trial:

Trial Title: Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age over 18~* Biopsy-proven alcoholic cirrhosis~* No previous HCC (treated or not)~* Excessive alcohol consumption, defined by more than 21 glasses weekly in women and more than 28 glasses weekly in men for at least 10 years, and considered as the main cause for liver cirrhosis~* Signed written informed consent~* Hepatic iron overload assessed by MRI (Iron hepatic concentration ≥ 80 μmol/g)~Exclusion Criteria:~* Subjects deprived of their liberty by judicial or administrative decision~* Pregnant women~* Serious associated short-term life threatening disease (except HIV viral co-infection, or the liver disease itself)~* Impossibility of monitoring, whatever the reason.~* Contraindication of phlebotomy~* Haemoglobin \<13.5 g/dL for men and \<12.5g/dL for women (threshold established by the French Blood Agency)~  * Congestive heart failure or coronary heart disease~ * Hepatic failure (TP\<60%), renal failure (GFR \<50 ml/min) or respiratory insufficiency (chronic dyspnea)~ * Poor venous system~* Complication of cirrhosis at time of inclusion (defined as bleeding related to portal hypertension, encephalopathy or ascites)~* Presence of hepatitis B or hepatitis C co-infection~* Presence of liver focal lesion suggestive of HCC~* Child-Pugh score greater than or equal to 7 (Class B or C) at time of inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- phlebotomy (Type: EXPERIMENTAL): None
- control (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).